Abstract
Streptococcus pneumoniae strains isolated from children of Krasnoyarsk (Siberia, Russian Federation) were examined. Authors determined Streptococcus pneumoniae serotypes and antimicrobial resistance. 16.7% of strains were multiple resistant with high MIC values for erythromycin, clindamycin and tetracycline (256, 128 and 32 mg/l, respectively). Prevalent serotypes were 23F and 19F. Most of serotypes (90%) belonged to those included in pneumococcal vaccines.
-
1.
World Health Organization. Pneumococcal conjugate vaccine for childhood immunization – WHO position paper. Wkly Epidemiol Rec 2007; 82:93-104.
-
2.
World Health Organization. Progress in introduction of pneumococcal conjugate vaccine worldwide, 2000-2012. Wkly Epidemiol Rec 2013; 88:173-80.
-
3.
O’Brien K.L., Wolfson L.J., Watt J.P., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374:893-902.
-
4.
World Health Organization. Pneumococcal vaccines – WHO position paper. Wkly Epidemiol Rec 2012; 87:129-44.
-
5.
Vuori-Holopainen E., Peltola H. Reappraisal of lung tap: review of an old method for better etiologic diagnosis of childhood pneumonia. Clin Infect Dis 2001; 32:715-26.
-
6.
Johnson H.L., Deloria-Knoll M., Levine O.S., et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 2010; 7:e1000348.
-
7.
Kyaw M.H., Lynfield R., Schaffner W., et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006; 354:145-63.
-
8.
Reinert R.R. The antimicrobial resistance profile of Streptococcus pneumoniae. Clin Microbiol Infect 2009; 15 (Suppl 3):7-11.
-
9.
Козлов Р.С., Сивая О.В., Кречикова О.И., Иванчик Н.В. Динамика резистентности Streptococcus pneumoniae к антибиотикам в России за период 1999- 2009 гг. (Результаты многоцентрового исследования «ПеГАС». Клин микробиол антимикроб химиотер 2010; 12:329-41.
-
10.
Grohs P., Trieu-Cuot P., Podglajen I., et al. Molecular basis for different levels of tet(M) expression in Streptococcus pneumoniae clinical isolates. Antimicrob Agents Chemother 2012; 56:5040-5.
-
11.
Савинова Т.А., Филимонова О.Ю., Грудинина С.А., Сидоренко С.В. Генетическое разнообразие пенициллиноустойчивых Streptococcus pneumoniae. Журн инфектол 2009; 1:66-71.
-
12.
Reinert R.R., Filimonova O.Y., Al-Lahham A., et al. Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia. Antimicrob Agents Chemother 2008; 52:2260-2.
-
13.
Кречикова О.И., Козлов Р.С., Богданович Т.М., и др. Выделение, идентификация и определение чувствительности к антибиотикам Streptococcus pneumoniae (методические рекомендации). Клин микробиол антимикроб химиотер 2000; 2:88-98.
-
14.
CLSI. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. CLSI document M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
-
15.
The European Committee on Antimicrobial Susceptibility Testing – EUCAST. Available from: URL: http://www.eucast.org/
-
16.
Soriano F., Gimenez M.J., Aguilar L. Cefditoren in upper and lower community-acquired respiratory tract infections. Drug Des Devel Ther 2011; 5:85-94.
-
17.
Grayson M.L., Crowe S.M., McCarty J.S., et al., editors. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. 6th ed. CRC Press; 2010.
-
18.
Streptococcus Laboratory. Available from: URL: http://www.cdc.gov /ncidod/biotech/strep/protocols.htm
-
19.
Савинова Т.А. Генетическое разнообразие и молекулярные основы резистентности Streptococcus pneumoniae к β-лактамным антибиотикам. Автореф. дисс… канд. биол. наук. М., 2011.
-
20.
Бахарева Н.В., Протасова И.Н., Перьянова О.В. и др. Бактерионосительство Streptococcus pneumoniae среди детей г. Красноярска. Эпидемиол и вакцинопроф 2012; 4:73-7.